
An ACCP speaker explains that the FDA faces a multitude of challenges.
An ACCP speaker explains that the FDA faces a multitude of challenges.
Julie Sibbesen, PharmD, discussed strategies to address medical misinformation and educate pharmacists on proper sources of information.
The guidelines emphasize the importance of vaccination, risk assessment, and preparedness for immunocompromised patients who are traveling post-transplant.
The KEYNOTE-756 and CheckMate 7FL trials show this combination improves pathological complete response rates in this patient population.
Pharmacogenomic testing can help identify patients' genetic profiles, revealing why certain drugs may be less effective or cause adverse effects.
The FDA faces a multitude of challenges in regulating artificial intelligence (AI) and machine learning (ML) medical devices.
Experts discuss challenges and recommendations for addressing diversity, equity, and inclusion in pharmacy programs for minority students.